Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Takeda Pharmaceutical ADR | TAK | 25. nov 2024 | 13.49 | +0.82 |
TAL Education Group ADR | TAL | 25. nov 2024 | 10.11 | +3.91 |
Talen Energy | TLN | 25. nov 2024 | 209.34 | -2.27 |
Talkspace | TALK | 25. nov 2024 | 3.43 | -0.58 |
Talos Energy | TALO | 25. nov 2024 | 11.30 | -1.31 |
Talphera | TLPH | 25. nov 2024 | 0.73 | +4.98 |
Tamboran Resources | TBN | 25. nov 2024 | 17.25 | 0.00 |
Tandem Diabetes Care | TNDM | 25. nov 2024 | 30.42 | -1.27 |
Tanger | SKT | 25. nov 2024 | 36.67 | +0.49 |
Tango Therapeutics | TNGX | 25. nov 2024 | 3.80 | -3.06 |
Tantech | TANH | 25. nov 2024 | 0.15 | -1.13 |
Taoping | TAOP | 25. nov 2024 | 0.34 | +0.56 |
Tapestry | TPR | 25. nov 2024 | 60.85 | +3.28 |
Targa Resources | TRGP | 25. nov 2024 | 201.06 | -3.01 |
Target | TGT | 25. nov 2024 | 130.53 | +4.42 |
Target Global Acquisition I A | TGAA | 25. nov 2024 | 11.35 | 0.00 |
Target Global Acquisition I Unit | TGAAU | 25. nov 2024 | 11.28 | 0.00 |
Target Hospitality | TH | 25. nov 2024 | 8.42 | -3.33 |
Tarsus Pharmaceuticals | TARS | 25. nov 2024 | 48.32 | +0.17 |
Taseko Mines | TGB | 25. nov 2024 | 2.06 | -0.96 |
TaskUs A | TASK | 25. nov 2024 | 15.12 | +2.02 |
TAT Technologies | TATT | 25. nov 2024 | 22.36 | +0.56 |
Taylor Devices | TAYD | 25. nov 2024 | 46.62 | +0.47 |
Taylor Morrison Home | TMHC | 25. nov 2024 | 74.80 | +5.23 |
Taysha Gene Therapies | TSHA | 25. nov 2024 | 2.89 | +17.00 |
TC Bancshares | TCBC | 25. nov 2024 | 13.10 | 0.00 |
TC Biopharm ADR | TCBP | 25. nov 2024 | 0.66 | +5.15 |
TC Energy | TRP | 25. nov 2024 | 49.06 | -1.58 |
TCTM Kids IT Education ADR | TCTM | 25. nov 2024 | 0.83 | +2.46 |
TCW Strategic | TSI | 25. nov 2024 | 4.97 | +0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.